Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-014963
Filing Date
2025-06-13
Accepted
2025-06-13 07:17:07
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8626
  Complete submission text file 0001641172-25-014963.txt   10728
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address WILLOW HOUSE, CRICKET SQUARE PO BOX 709 GRAND CAYMAN E9 KY1 - 1107
Business Address WILLOW HOUSE, CRICKET SQUARE PO BOX 709 GRAND CAYMAN E9 KY1 - 1107 44 7766 766766
Corvus Capital Ltd. (Reporting) CIK: 0001990829 (see all company filings)

State of Incorp.: E9
Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 251044737

Mailing Address LE MANOIR DE LURIN SAINT BARTHELEMY Z0 97133
Business Address
Regan Andrew (Reporting) CIK: 0001991325 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 251044738